LP
LPTI.US Longport Inc
- Market cap
- USD 2.31K
- P/E
- -
- P/B
- -
- ROE
- -132.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2005.
Is LPTI.US undervalued?
Graham numberThe Graham number of Longport Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Longport Inc fundamental analysis
No fundamental analysis for Longport Inc yet.
Longport Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Longport Inc
Longport, Inc. develops, manufactures, markets, and sells high resolution ultrasound imaging systems primarily in the United States. It offers EPISCAN I-200, a high frequency ultrasound imaging system that utilizes ultrasound at frequencies between 20 and 50MHz to image the skin and underlying soft tissue. The company's products are used in wound assessment, wound prevention, dermatology, and aesthetics/plastics, as well as in various other applications. It also exports its …
Full company profileLongport Inc financial statements
2005 annualized: Fiscal year 2005 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2005, the balance sheet is the latest quarter. Figures change when the annual report is published.
Longport Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 281K | 252K | 444K | 500K | 2.46M | 802K |
| Gross Profit | - | 168K | 377K | 275K | 1.35M | 666K |
| Operating Income | - | -1.82M | -761K | -872K | -288K | -1.28M |
| Net Income | - | -1.16M | -826K | -928K | -634K | -1.32M |
| Balance Sheet | ||||||
| Total Assets | 1.90M | 1.38M | 835K | 603K | 2.70M | 2.25M |
| Total Liabilities | 198K | 401K | 452K | 741K | 1.79M | 1.25M |
| Shareholders' Equity | 1.70M | 976K | 383K | -138K | 904K | 997K |
| Cash & Short-term Investments | 269K | 154K | 60.7K | 156K | 939K | 72.5K |
| Cash Flow | ||||||
| Operating Cash Flow | - | -181K | -309K | -340K | -142K | -1.54M |
| Capital Expenditure | 462K | 117K | 3.24K | 14.2K | 262K | 149K |
| Ratios | ||||||
| ROE | - | -118.9% | -215.7% | - | -70.1% | -132.7% |
| ROA | - | -84.3% | -99.0% | -153.9% | -23.5% | -58.8% |
| Net Profit Margin | - | -460.6% | -185.9% | -185.4% | -25.8% | -164.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Longport Inc dividends
Longport Inc has not paid dividends in the last 5 fiscal years.
Who owns Longport Inc
Ownership data of Longport Inc is not available yet.
Longport Inc company profile
- Company name
- Longport Inc
- Ticker
- LPTI.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 8
- Fiscal year end
- December
- Address
- 1620 Baltimore Pike, Chadds Ford, PA, United States, 19317
- Phone
- 610-361-9100
- Website
- longportinc.com
About Longport Inc
Longport, Inc. develops, manufactures, markets, and sells high resolution ultrasound imaging systems primarily in the United States. It offers EPISCAN I-200, a high frequency ultrasound imaging system that utilizes ultrasound at frequencies between 20 and 50MHz to image the skin and underlying soft tissue. The company's products are used in wound assessment, wound prevention, dermatology, and aesthetics/plastics, as well as in various other applications. It also exports its products. The company was founded in 1993 and is based in Chadds Ford, Pennsylvania.
Longport Inc management
3- Mr. Michael C. BoydChairman & CEO · born 1942
- Mr. Paul D. WilsonPresident, CFO, Director & MD of Longport International - UK · born 1958
- Mr. John P. CalabreseDirector of Sales and Marketing